Genetic variation in CYP19A1 and response to exemestane: Survival in early breast cancer in the Dutch TEAM trial

被引：0
|
作者：
Houtsma, Daniel
Fontein, Duveken
Wessels, Judith A. M.
Seynaeve, Caroline M.
Van de Velde, Cock J. H.
Nortier, J. W. R.
Guchelaar, Henk-jan
Gelderblom, Hans
机构：
[1] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, Leiden, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Med Oncol, Dr Daniel Den Hoed Canc Ctr, Rotterdam, Netherlands
[4] LUMC, Leiden, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10518
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Genetic variation in CYP19A1 and occurrence of adverse events in exemestane treatment with early breast cancer patients in the Dutch TEAM trial.
    Houtsma, Danny
    Fontein, Duveken
    van der Straaten, Tahar
    Baak-Pablo, Renee
    Wessels, Judith A. M.
    Seynaeve, Caroline
    De Velde, Cornelis J. H. Van
    Nortier, J. W. R.
    Gelderblom, Hans
    Guchelaar, Henk-Jan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Genetic polymorphisms of the CYP19A1 gene and breast cancer survival
    Long, Ji-Rong
    Kataoka, Nobuhiko
    Shu, Xiao-Ou
    Wen, Wanqing
    Gao, Yu-Tang
    Cai, Qiuyin
    Zheng, Wei
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (11) : 2115 - 2122
  • [3] Specific Adverse Events Predict Survival Benefit in Early Breast Cancer Patients Treated with Exemestane in the Dutch/Belgian TEAM Trial
    Fontein, D.
    Houtsma, D.
    Hille, E. T. M.
    Kranenbarg, W. M. Meershoek-Klein
    Putter, H.
    Seynaeve, C.
    Dirix, L. Y.
    Paridaens, R.
    van de Velde, C. J. H.
    Nortier, J. W. R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S101 - S101
  • [4] Genetic Variation an CYP19A1 and Risk of Breast Cancer and Fibrocystic Breast Conditions among Women in Shanghai, China
    Chen, Chu
    Sakoda, Lori C.
    Doherty, Jennifer A.
    Loomis, Melissa M.
    Fish, Sherianne
    Ray, Roberta M.
    Lin, Ming Gang
    Fan, Wenhong
    Zhao, Lue Ping
    Gao, Dao Li
    Stalsberg, Helge
    Feng, Ziding
    Thomas, David B.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (12) : 3457 - 3466
  • [5] Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole
    G. Lunardi
    P. Piccioli
    P. Bruzzi
    R. Notaro
    S. Lastraioli
    M. Serra
    P. Marroni
    C. Bighin
    M. Mansutti
    F. Puglisi
    M. Porpiglia
    R. Ponzone
    G. Bisagni
    O. Garrone
    G. Cavazzini
    M. Clavarezza
    L. Del Mastro
    [J]. Breast Cancer Research and Treatment, 2013, 137 : 167 - 174
  • [6] Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole
    Lunardi, G.
    Piccioli, P.
    Bruzzi, P.
    Notaro, R.
    Lastraioli, S.
    Serra, M.
    Marroni, P.
    Bighin, C.
    Mansutti, M.
    Puglisi, F.
    Porpiglia, M.
    Ponzone, R.
    Bisagni, G.
    Garrone, O.
    Cavazzini, G.
    Clavarezza, M.
    Del Mastro, L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (01) : 167 - 174
  • [7] CYP19A1 genetic variation is a potential predictor of outcome in ER-positive postmenopausal early breast cancer patients treated with tamoxifen
    Lo, Wing-Yee
    Schroth, Werner
    Hoppe, Reiner
    Schmidt, Marjanka
    Garcia-Closas, Montserrat
    Pharaoh, Paul
    Hall, Per
    Easton, Douglas
    Fasching, Peter
    Brauch, Hiltrud
    [J]. CANCER RESEARCH, 2015, 75
  • [8] Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women
    Haiman, Christopher A.
    Dossus, Laure
    Setiawan, V. Wendy
    Stram, Daniel O.
    Dunning, Alison M.
    Thomas, Gilles
    Thun, Michael J.
    Albanes, Demetrius
    Altshuler, David
    Ardanaz, Eva
    Boeing, Heiner
    Buring, Julie
    Burtt, Noel
    Calle, Eugenia E.
    Chanock, Stephen
    Clavel-Chapelon, Francoise
    Colditz, Graham A.
    Cox, David G.
    Feigelson, Heather Spencer
    Hankinson, Susan E.
    Hayes, Richard B.
    Henderson, Brian E.
    Hirschhorn, Joel N.
    Hoover, Robert
    Hunter, David J.
    Kaaks, Rudolf
    Kolonel, Laurence N.
    Le Marchand, Loic
    Lenner, Per
    Lund, Eiliv
    Panico, Salvatore
    Peeters, Petra H.
    Pike, Malcolm C.
    Riboli, Elio
    Tjonneland, Anne
    Travis, Ruth
    Trichopoulos, Dimitrios
    Wacholder, Sholom
    Ziegler, Regina G.
    [J]. CANCER RESEARCH, 2007, 67 (05) : 1893 - 1897
  • [9] Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients
    Roberta Ferraldeschi
    Monica Arnedos
    Kristen D. Hadfield
    Roger A’Hern
    Suzie Drury
    Andrew Wardley
    Anthony Howell
    D. Gareth Evans
    Stephen A. Roberts
    Ian Smith
    William G. Newman
    Mitch Dowsett
    [J]. Breast Cancer Research and Treatment, 2012, 133 : 1191 - 1198
  • [10] Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients
    Ferraldeschi, Roberta
    Arnedos, Monica
    Hadfield, Kristen D.
    A'Hern, Roger
    Drury, Suzie
    Wardley, Andrew
    Howell, Anthony
    Evans, D. Gareth
    Roberts, Stephen A.
    Smith, Ian
    Newman, William G.
    Dowsett, Mitch
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 1191 - 1198
12345